R7年度若手道場 特別講演
(Special Lecture 1) 1月29日(木)17:20~18:20水島 昇 先生東京大学大学院医学系研究科分子生物学 教授![]() オートファジーを基軸とした細胞内分解の研究
|
(Special Lecture 2) 1月30日(金)9:00~10:00John D. Scott 先生ワシントン大学医学部 薬理学部門 Edwin G. Krebs–Hilma Speights記念教授![]() John D. Scott is the Edwin G. Krebs–Hilma Speights Professor and Chair of the Department of Pharmacology at the University of Washington School of Medicine. He received his B.Sc. (Hons) degree in biochemistry from Herriot-Watt University, Edinburgh, and his Ph.D. from the University of Aberdeen. He did his postdoctoral research on protein kinase inhibitors under the guidance of Nobel Laurites Edwin Krebs and Edmund Fischer at the University of Washington. Scott is recognized for the discovery of AKAPs (A-kinase anchoring proteins), a large family of scaffold proteins that target signaling enzymes to specific cellular compartments. His work has markedly altered how we think about intracellular signaling. Whereas the enzymes that mediate intracellular signaling were previously thought to be soluble entities that diffuse freely throughout cells, we now know that they exist as components of large protein complexes that coordinate signaling events at defined cellular locations. Using genetic, structural, electrophysiological, and super-resolution imaging techniques, researchers have demonstrated that A-kinase anchoring proteins (AKAPs) enhance the precision of cellular signaling. This body of work has led to the proposal that AKAPs restrict the action of protein kinase A to a radius of 200-400 angstroms around subcellular organelles. In 2016, Dr. Scott was appointed Chair of the Department of Pharmacology at the University of Washington. These local responsibilities complement his broader service as a member of scientific advisory boards for research institutes and academic basic science departments in medical schools across the US, Australia, Asia, and Europe. Dr. Scott has received numerous accolades, including the Able and Axelrod awards from the American Society of Pharmacology and Therapeutics, the Rose Award from the American Society of Biochemistry and Molecular Biology, and the Ariens Award from the Dutch Pharmacology Society. He is a fellow of the Royal Society, London, the Royal Society of Edinburgh, and a member of the Norwegian Academy of Science and Letters. |

